Summit Therapeutics

Summit Therapeutics

Executive Director, Key Accounts Lead

Remote-Field (US) · Director

Sponsorship not specifiedDetected 2 days ago
Account ManagementNegotiationClinical TrialsLeadershipCollaboration

Stay score

odds of building a lasting career here

37Risky
Cap-exempt (no lottery)0
Sponsors this role80
Entry-level history0
PERM / green-card track0
Lottery odds40
Fits your clock70

Thin sponsorship signal and lottery-bound. A low-probability bet with your clock running. Prioritize cap-exempt roles and proven entry-level sponsors first.

Lottery odds assume a STEM candidate.

Personalize to your clock →

Employer immigration record

from this employer's Department of Labor filings

Files H-1B transfers

4 transfer filings in the last year, covering 4 workers. Median labor-condition decision: 7 days. An employer that already files transfers is one that can take over an existing H-1B.

Sourced from Department of Labor LCA, PERM and prevailing-wage disclosure data. Employer matching is by name, so figures may be split across an employer's legal entities. Absence of a filing means none appears in our copy of the data, not that none exists.

Community outcomes

No reports yet — be the first to help the next applicant.

About the role

  • This is a critical customer facing role to helping to ensure broad access, reimbursement, and patient affordability.

Responsibilities

  • Strategy Development: Co-create strategies, tools, and tactics for the field team to communicate the product value proposition effectively and mitigate access barriers.
  • Collaborate on pricing and contracting strategies, HEOR evidence generation plans, patient support programs, payer marketing initiatives, and account management approaches.

Nice to have

  • Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people.
  • Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology.
  • Summit has multiple global Phase 3 clinical studies, including:
  • Non-small Cell Lung Cancer (NSCLC)
  • Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.
  • Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.
  • Colorectal Cancer (CRC)
  • Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.

Skills

  • Bachelor's degree in business, healthcare, or a related field; advanced degree preferred.
  • Minimum of 15+ years of experience in payer and/or GPO strategy, pricing, and reimbursement within the pharmaceutical industry
  • Minimum of 7+ years of focused account management experience in the oncology access marketplace
  • <li data-leveltext="" data-font="Symbol" data-listid="4" dat

Benefits

  • Alignment and Negotiation: Lead discussions with internal and external partners to ensure alignment on access, coverage, and reimbursement strategies.
  • Industry Insight: Stay informed on healthcare industry trends, payer policies, reimbursement processes, and competitive activity.
  • Experience, Education and Specialized Knowledge and

Company info

  • Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.

This listing is sourced directly from Summit Therapeutics's careers page and normalized into a canonical job model.